We are live on
!
Find out more
ACB
Aristotle Capital Boston Portfolio holdings
AUM
$1.61B
1-Year Est. Return
19.82%
This Fund
S&P 500
This Quarter
Est. Return
-0.97%
1 Year Est. Return
+19.82%
3 Year Est. Return
+51.6%
5 Year Est. Return
+74.11%
10 Year Est. Return
+400.29%
AUM
$4.26B
AUM Growth
-$105M
(-2.4%)
Cap. Flow
+$387K
Cap. Flow
% of AUM
0.01%
Top 10 Holdings %
Top 10 Hldgs %
17.57%
Holding
140
New
2
Increased
92
Reduced
42
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PETQ
PetIQ, Inc. Class A Common Stock
PETQ
|
+$17.8M |
| 2 |
KB Home
KBH
|
+$10.3M |
| 3 |
PRSU
Pursuit Attractions and Hospitality Inc
PRSU
|
+$9.42M |
| 4 |
J&J Snack Foods
JJSF
|
+$9.25M |
| 5 |
Huron Consulting
HURN
|
+$8.15M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
QTS
QTS REALTY TRUST, INC.
QTS
|
+$84.8M |
| 2 |
Charles River Laboratories
CRL
|
+$29.5M |
| 3 |
Evercore
EVR
|
+$13.2M |
| 4 |
PFPT
Proofpoint, Inc.
PFPT
|
+$12.3M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$10.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 20.15% |
| 2 | Healthcare | 17.71% |
| 3 | Technology | 17.37% |
| 4 | Financials | 15.39% |
| 5 | Consumer Discretionary | 7.73% |
Similar funds
SCI
GCP
BW
TLFA
HH
KCM
SCM
PRA
Aristotle Capital Boston's Q3 2021 Portfolio in Review
As of Q3 2021, Aristotle Capital Boston held 140 positions worth $4.26B, down 2.4% from $4.37B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Trading was light in Q3 2021: portfolio turnover was 4.3%. Aristotle Capital Boston opened 2 new positions and exited 4, leaving the 140-position portfolio largely intact.
By sector, the portfolio is most concentrated in Industrials at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Technology.
- Aristotle Capital Boston's largest Q3 2021 buy was J&J Snack Foods: 56,803 shares worth $8.68M.
- Aristotle Capital Boston added most to PetIQ, Inc. Class A Common Stock in Q3 2021, an estimated $17.8M increase.
- Aristotle Capital Boston's biggest Q3 2021 reduction was Charles River Laboratories, cutting an estimated $29.5M.
- Aristotle Capital Boston fully exited QTS REALTY TRUST, INC. in Q3 2021, selling an estimated $84.8M.
- Aristotle Capital Boston's ten largest holdings make up 18% of its $4.26B portfolio in Q3 2021.
- Aristotle Capital Boston opened 2 new positions and closed 4 in Q3 2021.
- Aristotle Capital Boston's portfolio value fell 2.4% quarter-over-quarter to $4.26B.
Based on Aristotle Capital Boston's 13F filing for Q3 2021, filed 15 Nov 2021.